Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022)
Tilray Brands (TLRY) posted Depreciation & Amortization (CF) of $34.1 million for Q3 2022, down 16.43% on a QoQ basis from $40.8 million in Q2 2022, and down 13.38% year-over-year from $39.3 million in Q3 2021.
Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022) Analysis & Trends
Tilray Brands' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $34.1 million for Q3 2022.
- Quarterly Depreciation & Amortization (CF) fell 13.38% year-over-year to $34.1 million in Q3 2022, while the trailing twelve-month figure through May 2023 was $34.1 million (down 77.96% YoY) and the FY2022 annual result came in at $154.6 million, up 127.9% from the prior year.
- Depreciation & Amortization (CF) was $34.1 million for Q3 2022 at Tilray Brands, down from $40.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $40.8 million in Q2 2022 and bottomed at $479000.0 in Q1 2018.
- A 5-year average of $16.8 million and a median of $11.5 million in 2020 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2018 — Depreciation & Amortization (CF) jumped 552.55% — and 2022, when it decreased 13.38%.
- Tilray Brands' Depreciation & Amortization (CF) stood at $2.9 million in 2018, then surged by 190.21% to $8.5 million in 2019, then surged by 40.86% to $12.0 million in 2020, then soared by 211.45% to $37.5 million in 2021, then declined by 9.08% to $34.1 million in 2022.
- Business Quant data shows TLRY's Depreciation & Amortization (CF) at $34.1 million in Q3 2022, $40.8 million in Q2 2022, and $37.0 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2022 | 34.07 Mn |
| Aug 31, 2022 | 34.07 Mn |
| May 31, 2022 | 40.77 Mn |
| May 31, 2022 | 40.77 Mn |
| Feb 28, 2022 | 37.02 Mn |
| Feb 28, 2022 | 37.02 Mn |
| Nov 30, 2021 | 37.47 Mn |
| Nov 30, 2021 | 37.47 Mn |
| Aug 31, 2021 | 39.33 Mn |
| Aug 31, 2021 | 39.33 Mn |
| May 31, 2021 | 24.54 Mn |
| May 31, 2021 | 24.54 Mn |
| Nov 30, 2020 | 12.03 Mn |
| Nov 30, 2020 | 12.03 Mn |
| Aug 31, 2020 | 10.98 Mn |
| Aug 31, 2020 | 10.98 Mn |
| May 31, 2020 | 25.21 Mn |
| May 31, 2020 | 25.21 Mn |
| Mar 31, 2020 | 4.56 Mn |
| Mar 31, 2020 | 4.56 Mn |